References

Premature mortality and causes of death among people with epilepsy: A nationwide population-based incident cohort study

10.1212/wnl.0000000000207212 · 2023 · External reference

Improving epilepsy diagnosis across the lifespan: Approaches and innovations

10.1016/s1474-4422(24)00079-6 · 2024 · External reference

Global, regional, and national burden of epilepsy, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

10.1016/s1474-4422(18)30454-x · 2019 · External reference

Epilepsy in adults

10.1016/s0140-6736(18)32596-0 · 2019 · External reference

Gut microbiota and epilepsy: A systematic review on their relationship and possible therapeutics

10.1021/acschemneuro.0c00431 · 2020 · External reference

Early assessment of responsive neurostimulation for drug-resistant epilepsy in China: A multicenter, self-controlled study

10.1097/cm9.0000000000003292 · 2025 · External reference

Gut microbiota manipulation as an epilepsy treatment

10.1016/j.nbd.2022.105897 · 2022 · External reference

A comprehensive review on the role of the gut microbiome in human neurological disorders

10.1128/cmr.00338-20 · 2022 · External reference

Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: Population based cohort study

2024 · External reference

Diet composition and sterilization modifies intestinal microbiome diversity and burden of Theiler’s virus infection-induced acute seizures

10.1111/epi.17946 · 2024 · External reference

Gut: The gate and key to brain

10.1097/cm9.0000000000003767 · 2025 · External reference

Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy

10.1016/j.bbi.2024.04.007 · 2024 · External reference

Ketogenic diet therapy for pediatric epilepsy is associated with alterations in the human gut microbiome that confer seizure resistance in mice

10.1016/j.celrep.2023.113521 · 2023 · External reference

Targeted gut microbiota manipulation attenuates seizures in a model of infantile spasms syndrome

10.1172/jci.insight.158521 · 2022 · External reference

Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases

10.1038/s41392-024-01743-1 · 2024 · External reference

Encyclopedia of fecal microbiota transplantation: A review of effectiveness in the treatment of 85 diseases

10.1097/cm9.0000000000002339 · 2022 · External reference

Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report

10.3748/wjg.v23.i19.3565 · 2017 · External reference

Nanjing consensus on methodology of washed microbiota transplantation

10.1097/cm9.0000000000000954 · 2020 · External reference

Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening

10.1007/s13238-019-00684-8 · 2020 · External reference

Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes

10.1016/j.cmet.2023.06.010 · 2023 · External reference

Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study

10.1186/s40168-016-0225-7 · 2017 · External reference

Fecal microbiota transplantation in an elderly patient with mental depression

10.1017/s1041610219000115 · 2019 · External reference

Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS

10.1212/nxi.0000000000000459 · 2018 · External reference

Fecal microbiota transplantation to treat Parkinson’s disease with constipation: A case report

2019 · External reference

Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis

10.1080/19490976.2024.2353396 · 2024 · External reference

Holdemanella biformis augments washed microbiota transplantation for the treatment of radiation enteritis

10.1136/gutjnl-2025-335230 · 2025 · External reference

Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: A phase 2b randomized clinical trial

10.1001/jamaneurol.2023.3542 · 2023 · External reference

Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis

10.1002/epi4.12923 · 2024 · External reference

Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy

10.1002/ana.25655 · 2020 · External reference

Evaluation of a new body-focused group therapy versus a guided self-help group program for adults with psychogenic non-epileptic seizures (PNES): A pilot randomized controlled feasibility study

10.1007/s00415-021-10652-0 · 2022 · External reference

Trimmomatic: A flexible trimmer for Illumina sequence data

10.1093/bioinformatics/btu170 · 2014 · External reference

Metagenomic microbial community profiling using unique clade-specific marker genes

10.1038/nmeth.2066 · 2012 · External reference

Species-level functional profiling of metagenomes and metatranscriptomes

10.1038/s41592-018-0176-y · 2018 · External reference

The gut microbiota mediates the anti-seizure effects of the ketogenic diet

10.1016/j.cell.2018.04.027 · 2018 · External reference

Microbiota regulate social behaviour via stress response neurons in the brain

10.1038/s41586-021-03669-y · 2021 · External reference

Pentylenetetrazole: A review

10.1016/j.neuint.2024.105841 · 2024 · External reference

COX-2-PGE(2) signaling pathway contributes to hippocampal neuronal injury and cognitive impairment in PTZ-kindled epilepsy mice

10.1016/j.intimp.2020.106801 · 2020 · External reference

Transcranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats

10.1186/s12906-022-03562-9 · 2022 · External reference

PTZ-induced seizures in mice require a revised Racine scale

10.1016/j.yebeh.2019.02.029 · 2019 · External reference

Akkermansia muciniphila is a promising probiotic

10.1111/1751-7915.13410 · 2019 · External reference

Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms

10.1016/j.ebiom.2022.103833 · 2022 · External reference

First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat

10.1111/epi.16813 · 2021 · External reference

Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: A systematic review of published prospective studies

10.1007/s12519-017-0053-2 · 2017 · External reference

Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet

10.1016/j.ebiom.2022.104061 · 2022 · External reference

The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: A pilot study

10.3920/bm2018.0018 · 2018 · External reference

Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease

10.1007/s00253-018-9447-x · 2019 · External reference

Fecal microbiota transplantation for ulcerative colitis: The optimum timing and gut microbiota as predictors for long-term clinical outcomes

10.14309/ctg.0000000000000224 · 2020 · External reference

Akkermansia in the gastrointestinal tract as a modifier of human health

10.1080/19490976.2024.2406379 · 2024 · External reference

Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response

10.1016/j.nbd.2022.105664 · 2022 · External reference

Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice

10.1038/srep16643 · 2015 · External reference

Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance

10.1038/s41564-021-00912-0 · 2021 · External reference

Bacteroides vulgatus SNUG 40005 restores Akkermansia depletion by metabolite modulation

10.1053/j.gastro.2022.09.040 · 2023 · External reference

Functional gastrointestinal disorders in patients with epilepsy: Reciprocal influence and impact on seizure occurrence

10.3389/fneur.2021.705126 · 2021 · External reference

Comorbidity and childhood epilepsy: A nationwide registry study

10.1542/peds.2016-0921 · 2016 · External reference

Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients

10.1016/j.seizure.2010.12.011 · 2011 · External reference

Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice

10.1161/circresaha.119.316448 · 2020 · External reference

Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis

10.1053/j.gastro.2018.12.001 · 2019 · External reference

Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson’s syndrome: A phase 2, single centre, randomised clinical trial

10.1016/j.eclinm.2023.101888 · 2023 · External reference

Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression

10.1038/s41380-022-01569-9 · 2022 · External reference

Akkermansia muciniphila supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses

10.1080/19490976.2023.2252764 · 2023 · External reference

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

10.1016/j.phrs.2021.105420 · 2021 · External reference

The role of short-chain fatty acids in microbiota-gut-brain communication

10.1038/s41575-019-0157-3 · 2019 · External reference